Skip to main content
Oncotarget logoLink to Oncotarget
. 2017 May 22;8(21):35480. doi: 10.18632/oncotarget.18067

Correction: Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin

Yu-Chen SH Yang, Yu-Tang Chin, Meng-Ti Hsieh, Hsuan-Yu Lai, Chien-Chih Ke, Dana R Crawford, Oscar K Lee, Earl Fu, Shaker A Mousa, Patricia Grasso, Leroy F Liu, Heng-Yu Chang, Heng-Yuan Tang, Hung-Yun Lin, Paul J Davis
PMCID: PMC5471071  PMID: 28545220

Present: A typographical error was made on Table 1 regarding the concentration of leptin injected to mice.

Table 1. Leptin and OB3 affect the circulating levels of hormones.

Control OB3 (1 mg/kg) Leptin (80 μg/kg)
FSH
(ng/ml)
0 hr 109.31 ± 3.07 82.71 ± 3.64 93.87 ± 5.69
2 hrs 113.06 ± 3.07 87.3 ± 2.73 99.19 ± 19.4
48 hrs 120.10 ± 1.93 116.44 ± 1.36** 147.56 ± 20.2***
LH
(ng/ml)
0 hr 4.44 ± 0.45 4.48 ± 0.63 5.76 ± 0.18
2 hrs 6.25 ± 0.12 6.1 ± 0.14 4.3 ± 0.29***
48 hrs 4.36 ± 0.08 4.5 ± 0.12 4.17 ± 1.07**
TSH
(pg/ml)
0 hr 113.52 ± 16.8 119.5 ± 30.9 118.4 ± 2.59
2 hrs 105.3 ± 14.4 95.82 ± 39.8 119.9 ± 7.58
48 hrs 115.1 ± 15.1 92.7 ± 6.27 128.7 ± 3.74*

(Mean ± SD, ** p < 0.01, *** p < 0.001, were compared with 0 hr)

Correct: The proper Table is given below.

Original article: Oncotarget. 2016; 7:27641-27654. doi: 10.18632/oncotarget.8505


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES